Alexander Spira, MD, Oncology, Fairfax, VA, Inova Alexandria Hospital

AlexanderISpiraMD

Oncology Fairfax, VA

Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology, Sarcoma, Thoracic Cancer

Virginia Cancer Specialists

Dr. Spira is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Spira's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Medical Oncology, 2000 - 2003
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1997 - 2000
  • NYU School of Medicine
    NYU School of MedicineClass of 1997

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2003 - 2022
  • MD State Medical License
    MD State Medical License 2000 - 2003
  • PA State Medical License
    PA State Medical License 1998 - 2000
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Top Doctors:Washington DC Area Castle Connolly, 2012
  • Top Doctors:Washington-Baltimore Castle Connolly, 2012
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Safety, Efficacy and Biomarker Analysis of a Phase 1b/2 Study of Onvansertib (ONV), a Polo-like Kinase 1 (PLK1) Inhibitor, in Combination with Low-Dose Cytarabine (LDA...
    Alexander I. Spira, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Interim Futility Analysis of a Phase 2 Study of Loncastuximab Tesirine, a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Patients with Relapsed or Refra...
    Alexander I. Spira, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • The Impact of Immunotherapy on a Community Practice. Integrating Immunotherapy Into Clinical Practice: Changes Over the Past Year (Part 2) 
    2018 ASCO Annual Meeting - Chicago, Illinois - 05/31/2018

Authored Content

  • Exploring Why Testing in Lung Cancer Is Important to Treatment DecisionsDecember 2020
  • Cell-Free DNA NGS Prediction of Response and Resistance to a 3rd-Generation EGFR InhibitorAugust 2018

Press Mentions

  • Clinical Challenges: Second-Line Treatment for NSCLC After Failure of Immunotherapy
    Clinical Challenges: Second-Line Treatment for NSCLC After Failure of ImmunotherapyJune 29, 2020 09:33
  • Advanced Soft Tissue Sarcomas: Dox + Olaratumab vs. Dox + PBO
    Advanced Soft Tissue Sarcomas: Dox + Olaratumab vs. Dox + PBOJune 02, 2019 23:10
  • Augmedix’s EHR Documentation Platform Enters Innovative Pilot with Award-Winning iKnowMed Oncology EHR
    Augmedix’s EHR Documentation Platform Enters Innovative Pilot with Award-Winning iKnowMed Oncology EHRDecember 06, 2018 17:38
  • Join now to see all

Professional Memberships

Hospital Affiliations